AAAAAA

   
Results: 1-10 |
Results: 10
RELATIONSHIPS BETWEEN SEVERE NEONATAL THROMBOCYTOPENIA AND MATERNAL CHARACTERISTICS IN PREGNANCIES ASSOCIATED WITH AUTOIMMUNE THROMBOCYTOPENIA
Authors: VALAT AS CAULIER MT DEVOS P RUGERI L WIBAUT B VAAST P PUECH F BAUTERS F JUDE B
Citation: As. Valat et al., RELATIONSHIPS BETWEEN SEVERE NEONATAL THROMBOCYTOPENIA AND MATERNAL CHARACTERISTICS IN PREGNANCIES ASSOCIATED WITH AUTOIMMUNE THROMBOCYTOPENIA, British Journal of Haematology, 103(2), 1998, pp. 397-401
ASSOCIATION BETWEEN THE LUPUS ANTICOAGULANT (LA) BIOLOGICAL PROFILE AND THROMBOSIS
Authors: SIAKA C CARON C RUGERI L TOURNOYS A GOUDEMAND J
Citation: C. Siaka et al., ASSOCIATION BETWEEN THE LUPUS ANTICOAGULANT (LA) BIOLOGICAL PROFILE AND THROMBOSIS, British Journal of Haematology, 102(1), 1998, pp. 247-247
PLASMA-FREE TISSUE FACTOR PATHWAY INHIBITOR ARE INCREASED IN PATIENTSWITH IDDM
Authors: RUGERI L VAMBERGUE A GAVERIAUX V AMIRAL J FONTAINE P JUDE B
Citation: L. Rugeri et al., PLASMA-FREE TISSUE FACTOR PATHWAY INHIBITOR ARE INCREASED IN PATIENTSWITH IDDM, British Journal of Haematology, 102(1), 1998, pp. 258-258
LABORATORY DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA - COMPARISONOF THE DIAGNOSIS VALUE OF PLATELET-AGGREGATION TEST AND PLATELET-FACTOR-4 HEPARIN COMPLEXES ELISA
Authors: BAUTERS A ZAWADZKI C TRILLOT N WATEL A RUGERI L JUDE B
Citation: A. Bauters et al., LABORATORY DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA - COMPARISONOF THE DIAGNOSIS VALUE OF PLATELET-AGGREGATION TEST AND PLATELET-FACTOR-4 HEPARIN COMPLEXES ELISA, British Journal of Haematology, 102(1), 1998, pp. 262-262
USE OF A FUNCTIONAL TEST BASED ON THE VON-WILLEBRAND-FACTOR COLLAGENEBINDING (CBA) IN THE BIOLOGICAL MONITORING OF WILLEBRAND-DISEASE TREATMENT
Authors: CARON C RUGERI L SIAKA C TOURNOYS A GOUDEMAND J
Citation: C. Caron et al., USE OF A FUNCTIONAL TEST BASED ON THE VON-WILLEBRAND-FACTOR COLLAGENEBINDING (CBA) IN THE BIOLOGICAL MONITORING OF WILLEBRAND-DISEASE TREATMENT, British Journal of Haematology, 102(1), 1998, pp. 262-262
OUTCOME OF A QUALITY APPROACH FOR TRANSFU SION SAFETY ON PRESCRIPTION, CIRCUIT IMPROVEMENT AND BLOOD PRODUCT MARKING OUT - EXAMPLE OF CHRU,LILLE
Authors: MAREY A COUPEZ B GRUCA L VANNIER V RENOM P WIBAUT B RUGERI L COSSEMENT C COSSON A
Citation: A. Marey et al., OUTCOME OF A QUALITY APPROACH FOR TRANSFU SION SAFETY ON PRESCRIPTION, CIRCUIT IMPROVEMENT AND BLOOD PRODUCT MARKING OUT - EXAMPLE OF CHRU,LILLE, Transfusion clinique et biologique, 4(5), 1997, pp. 469-484
ASSAYING FACTOR-XIII IN PLASMA - ADAPTATION OF PHOTOMETRIC-METHOD ANDCLINICAL-EVALUATION
Authors: TOURNOYS A RUGERI L CARON C GOUDEMAND J
Citation: A. Tournoys et al., ASSAYING FACTOR-XIII IN PLASMA - ADAPTATION OF PHOTOMETRIC-METHOD ANDCLINICAL-EVALUATION, Thrombosis and haemostasis, 1997, pp. 133-133
ACQUIRED FACTOR-V INHIBITOR CLINICALLY WELL-TOLERATED - A 3 YEARS FOLLOW-UP
Authors: RUGERI L TOURNOYS A CARON C READE V GOUDEMAND J
Citation: L. Rugeri et al., ACQUIRED FACTOR-V INHIBITOR CLINICALLY WELL-TOLERATED - A 3 YEARS FOLLOW-UP, Thrombosis and haemostasis, 1997, pp. 885-885
USEFULNESS OF A FUNCTIONAL TEST BASED ON THE VON-WILLEBRAND FACTOR-COLLAGEN BINDING TO CLASSIFY VON-WILLEBRAND PATIENTS
Authors: CARON C RUGERI L READE V TOURNOYS A GOUDEMAND J
Citation: C. Caron et al., USEFULNESS OF A FUNCTIONAL TEST BASED ON THE VON-WILLEBRAND FACTOR-COLLAGEN BINDING TO CLASSIFY VON-WILLEBRAND PATIENTS, Thrombosis and haemostasis, 1997, pp. 2573-2573
DECREASE OF MONOCYTE TISSUE FACTOR EXPRESSION IN HYPERLIPEMIC PATIENTS
Authors: RUGERI L SUSEN S GAVERIAUX V LECERF JM BARD JM LUC G CORSEAUX D COSSON A JUDE B
Citation: L. Rugeri et al., DECREASE OF MONOCYTE TISSUE FACTOR EXPRESSION IN HYPERLIPEMIC PATIENTS, Blood, 86(10), 1995, pp. 3684-3684
Risultati: 1-10 |